22.7 C
Lagos
Monday, August 11, 2025

Mail

spot_img

Nigeria Retains WHO Maturity Level 3 Status for Medicine Regulation

Nigeria has reaffirmed its position as a leading health regulator in Africa, with the World Health Organization (WHO) confirming the country’s sustained Maturity Level 3 (ML3) status for the regulation of medicines and vaccines.

The National Agency for Food and Drug Administration and Control (NAFDAC) announced the milestone in a statement signed by its Director-General, Prof. Mojisola Adeyeye, on August 7, 2025.

The ML3 status, officially sustained as of June 30, 2025, means Nigeria’s regulatory system is considered “stable, well-functioning, and integrated” under WHO’s Global Benchmarking Tool (GBT).

Rigorous Assessments and Global Recognition

This achievement follows a formal WHO re-benchmarking exercise conducted in Abuja and Lagos from November 25 to 29, 2024. It was complemented by five Institutional Development Plan (IDP) meetings held between February and May 2025.

The sessions reviewed NAFDAC’s progress in implementing WHO’s key recommendations. Nigeria successfully closed all critical gaps, confirming its regulatory system meets international standards.

“This milestone affirms NAFDAC’s stable, well-integrated regulatory system,” the agency stated. “It reinforces confidence in Nigeria’s oversight of medicine and vaccine safety, quality, and efficacy.”

Nigeria remains the first and only National Regulatory Authority (NRA) in Africa to achieve and maintain WHO ML3 status.

Prof. Adeyeye praised the agency’s staff, saying, “Their efforts have made Nigeria a model for regulatory excellence in Africa.”

What This Means for Nigeria’s Health Sector

The ML3 status is a major step toward WHO listing of Nigerian-made medicines and vaccines for international procurement. It also boosts Nigeria’s credibility in global health governance and opens doors for pharmaceutical exports.

WHO said the accomplishment supports universal health coverage and the Sustainable Development Goals. Follow-up visits will be conducted within a year, and another re-benchmarking exercise is scheduled in four years to assess sustainability.

NAFDAC pledged to continue improving regulatory standards, protecting public health, and strengthening Nigeria’s role in the global health ecosystem.

Any idea what impact this recognition will have on Nigeria’s pharmaceutical exports and access to safe medicine? Share your thoughts.
0
Any idea what impact this recognition will have on Nigeria’s pharmaceutical exports and access to safe medicine? Share your thoughts.x
Rate, Like 👍, Comment💬, share this article, Follow us on our social media handles, and Submit your own story to get featured and earn rewards!
0 0 votes
Article Rating
- Advertisement -
spot_imgspot_img
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
spot_img
Chinelobi Daniel
Chinelobi Danielhttp://joliba.com.ng
JolibaLive | The Information Market Place 🌍 Citizen's companion. Democratized journalism
LISTEN TO THE NEWS

Related Articles

Click Target 💠 For Your Local Weather Update

Lagos
scattered clouds
22.5 ° C
22.5 °
22.5 °
94 %
1.1kmh
41 %
Mon
27 °
Tue
27 °
Wed
27 °
Thu
23 °
Fri
24 °
- Advertisement -spot_imgspot_img

Follow Us

1,647FansLike
8FollowersFollow
0FollowersFollow
0FollowersFollow
27FollowersFollow
4SubscribersSubscribe

Subscribe to our Newsletter

Latest news updates sent each morning direct to your mailbox.

Latest Articles

0
Would love your thoughts, please comment.x
()
x